Cresset Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-11,182
Closed -$60.9K – 1836
2026
Q1
$60.9K Buy
+11,182
New +$62.7K ﹤0.01% 1572
2025
Q2
– Sell
-10,353
Closed -$82.4K – 1763
2025
Q1
$82.4K Sell
10,353
-11,881
-53% -$120K ﹤0.01% 1629
2024
Q4
$202K Sell
22,234
-83,430
-79% -$806K ﹤0.01% 1563
2024
Q3
$970K Buy
105,664
+41,541
+65% +$344K ﹤0.01% 1179
2024
Q2
$627K Buy
64,123
+8,219
+15% +$100K ﹤0.01% 1336
2024
Q1
$844K Sell
55,904
-3,290
-6% -$59.7K ﹤0.01% 1062
2023
Q4
$1.28M Buy
59,194
+8,200
+16% +$151K 0.01% 791
2023
Q3
$948K Sell
50,994
-9
-0% -$210 ﹤0.01% 877
2023
Q2
$1.29M Buy
+51,003
New +$1.28M ﹤0.01% 822
2022
Q4
– Sell
-23,751
Closed -$602K – 876
2022
Q3
$602K Buy
23,751
+692
+3% +$24.3K 0.01% 464
2022
Q2
$766K Sell
23,059
-304
-1% -$12.9K 0.01% 433
2022
Q1
$1.69M Buy
23,363
+875
+4% +$63K 0.02% 277
2021
Q4
$2.06M Sell
22,488
-1,379
-6% -$165K 0.02% 294
2021
Q3
$3.03M Buy
23,867
+895
+4% +$130K 0.04% 163
2021
Q2
$3.82M Buy
22,972
+5,036
+28% +$816K 0.05% 137
2021
Q1
$3.26M Buy
17,936
+11,333
+172% +$2.63M 0.05% 129
2020
Q4
$1.32M Buy
6,603
+2,770
+72% +$563K 0.02% 204
2020
Q3
$841K Buy
+3,833
New +$812K 0.02% 259
2019
Q2
– Sell
-113
Closed -$6K – 1558
2019
Q1
$6K Buy
113
+30
+36% +$1.83K ﹤0.01% 1317
2018
Q4
$4K Buy
+83
New +$5.08K ﹤0.01% 1121

Other funds holding TDOC

Cresset Asset Management's TDOC Position: Q2 2026 in Review

Cresset Asset Management sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 11,182 shares — an estimated $60.9K sold.

Cresset Asset Management first reported a position in TDOC in Q4 2018 and held it in 20 quarters. The position peaked at $3.82M in Q2 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Cresset Asset Management reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • Cresset Asset Management sold 11,182 Teladoc Health shares in Q2 2026, an estimated $60.9K.
  • Cresset Asset Management first reported a position in Teladoc Health in Q4 2018 and held it in 20 quarters.
  • Cresset Asset Management's Teladoc Health position peaked at $3.82M in Q2 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.